AAAAAA
Results:
1-21
|
Results: 21
Authors:
Ritz, U
Seliger, B
Citation: U. Ritz et B. Seliger, The transporter associated with antigen processing (TAP): Structural integrity, expression, function, and its clinical relevance, MOL MED, 7(3), 2001, pp. 149-158
Authors:
Ritz, U
Momburg, F
Pilch, H
Huber, C
Maeurer, MJ
Seliger, B
Citation: U. Ritz et al., Deficient expression of components of the MHC class I antigen processing machinery in human cervical carcinoma, INT J ONCOL, 19(6), 2001, pp. 1211-1220
Authors:
Li, J
Schuler-Thurner, B
Schuler, G
Huber, C
Seliger, B
Citation: J. Li et al., Bipartite regulation of different components of the MHC class I antigen-processing machinery during dendritic cell maturation, INT IMMUNOL, 13(12), 2001, pp. 1515-1523
Authors:
Ritz, U
Momburg, F
Pircher, HP
Strand, D
Huber, C
Seliger, B
Citation: U. Ritz et al., Identification of sequences in the human peptide transporter subunit TAP1 required for transporter associated with antigen processing (TAP) function, INT IMMUNOL, 13(1), 2001, pp. 31-41
Authors:
Lichtenfels, R
Ackermann, A
Kellner, R
Seliger, B
Citation: R. Lichtenfels et al., Mapping and expression pattern analysis of key components of the major histocompatibility complex class I antigen processing and presentation pathwayin a representative human renal cell carcinoma cell line, ELECTROPHOR, 22(9), 2001, pp. 1801-1809
Authors:
Hombach, A
Wieczarkowiecz, A
Marquardt, T
Heuser, C
Usai, L
Pohl, C
Seliger, B
Abken, H
Citation: A. Hombach et al., Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can ge integrated into one combined CD28/CD3 zeta signaling receptor molecule, J IMMUNOL, 167(11), 2001, pp. 6123-6131
Authors:
Hombach, A
Sent, D
Schneider, C
Heuser, C
Koch, D
Pohl, C
Seliger, B
Abken, H
Citation: A. Hombach et al., T-cell activation by recombinant receptors: CD28 costimulation is requiredfor interleukin 2 secretion and receptor-mediated T-cell proliferation butdoes not affect receptor-mediated target cell lysis, CANCER RES, 61(5), 2001, pp. 1976-1982
Authors:
Seliger, B
Wollscheid, U
Momburg, F
Blankenstein, T
Huber, C
Citation: B. Seliger et al., Characterization of the major histocompatibility complex class I deficiencies in B16 melanoma cells, CANCER RES, 61(3), 2001, pp. 1095-1099
Authors:
Wang, J
Golbik, R
Seliger, B
Spinka, M
Tittmann, K
Hubner, G
Jordan, F
Citation: J. Wang et al., Consequences of a modified putative substrate-activation site on catalysisby yeast pyruvate decarboxylase, BIOCHEM, 40(6), 2001, pp. 1755-1763
Authors:
Seliger, B
Schreiber, K
Delp, K
Meissner, M
Hammers, S
Reichert, T
Pawlischko, K
Tampe, R
Huber, C
Citation: B. Seliger et al., Downregulation of the constitutive tapasin expression in human tumor cellsof distinct origin and its transcriptional upregulation by cytokines, TISSUE ANTI, 57(1), 2001, pp. 39-45
Authors:
Delp, K
Momburg, F
Hilmes, C
Huber, C
Seliger, B
Citation: K. Delp et al., Functional deficiencies of components of the MHC class I antigen pathway in human tumors of epithelial origin, BONE MAR TR, 25, 2000, pp. S88-S95
Authors:
Seliger, B
Maeurer, MJ
Ferrone, S
Citation: B. Seliger et al., Antigen-processing machinery breakdown and tumor growth, IMMUNOL TOD, 21(9), 2000, pp. 455-464
Authors:
Seliger, B
Rongcun, Y
Atkins, D
Hammers, S
Huber, C
Storkel, S
Kiessling, R
Citation: B. Seliger et al., HER-2/neu is expressed in human renal cell carcinoma at heterogeneous levels independently of tumor grading and staging and can be recognized by HLA-A2.1-restricted cytotoxic T lymphocytes, INT J CANC, 87(3), 2000, pp. 349-359
Authors:
Seliger, B
Kono, K
Rongcun, Y
Kiessling, R
Citation: B. Seliger et al., Cytotoxic T cell epitopes and tissue distribution of the HER-2/neu proto-oncogene: Implications for vaccine development, MED INTEL U, 24, 2000, pp. 121-142
Authors:
Seliger, B
Wollscheid, U
Momburg, F
Blankenstein, T
Huber, C
Citation: B. Seliger et al., Coordinate downregulation of multiple MHC class I antigen processing genesin chemical-induced murine tumor cell lines of distinct origin, TISSUE ANTI, 56(4), 2000, pp. 327-336
Authors:
Trinder, P
Seitzer, U
Gerdes, J
Seliger, B
Maeurer, M
Citation: P. Trinder et al., Constitutive and IFN-gamma regulated expression of IL-7 and IL-15 in humanrenal cell cancer, INT J ONCOL, 14(1), 1999, pp. 23-31
Authors:
Jung, D
Hilmes, C
Knuth, A
Jaeger, E
Huber, C
Seliger, B
Citation: D. Jung et al., Gene transfer of the co-stimulatory molecules B7-1 and B7-2 enhances the immunogenicity of human renal cell carcinoma to a different extent, SC J IMMUN, 50(3), 1999, pp. 242-249
Authors:
Maeurer, M
Seliger, B
Trinder, P
Gerdes, J
Seitzer, U
Citation: M. Maeurer et al., Interleukin-15 in mycobacterial infection of antigen-presenting cells, SC J IMMUN, 50(3), 1999, pp. 280-288
Authors:
Hohn, H
Pilch, H
Gunzel, S
Neukirch, C
Hilmes, C
Kaufmann, A
Seliger, B
Maeurer, MJ
Citation: H. Hohn et al., CD4(+) tumor-infiltrating lymphocytes in cervical cancer recognize HLA-DR-restricted peptides provided by human papillomavirus-E7, J IMMUNOL, 163(10), 1999, pp. 5715-5722
Authors:
Jager, E
Hohn, H
Karbach, J
Momburg, F
Castelli, C
Knuth, A
Seliger, B
Maeurer, MJ
Citation: E. Jager et al., Cytotoxic T lymphocytes define multiple peptide isoforms derived from the melanoma-associated antigen MART-1/Melan-A, INT J CANC, 81(6), 1999, pp. 979-984
Authors:
Kallfelz, M
Jung, D
Hilmes, C
Knuth, A
Jaeger, E
Huber, C
Seliger, B
Citation: M. Kallfelz et al., Induction of immunogenicity of a human renal-cell carcinoma cell line by TAP1-gene transfer, INT J CANC, 81(1), 1999, pp. 125-133
Risultati:
1-21
|